I know people are looking at the IBB. IMO- The future outlooks on drug sales are hard to figure given the uncertainty of subsidized healthcare, government pressure on doctors concerning the prescribing pain killers, and now a renewed attack on drug pricing. Everyone here is getting older and along with the rest of the industrialized populations have become accustomed to instant gratification, lower thresholds when it comes to tolerating pain and disruptions to their lifestyles. Opioids are a cheap and effective choice. So, when you balance out these factors, I do not see a significant contraction coming in opiate demand.
There is a worldwide contraction, decreasing jobs being reported today etc. Heightened investor concerns about near term spending requirements and the perception of limited resources to acquire inexpensive financing is understandable. Fortunes are going to be made by those holding shares in companies that have developments that eliminate need for near term financing. My focus is: What are our catalysts? How soon will they arrive and how will these affect the company's financial outlook. I think we are close and we will have good news soon. I'm wondering for trading purposes: Is the PPS response to good news (approvals, partnerships etc.) be muted by the weakness in this sector and market or be accentuated by inflows caused by the lack of other good alternatives in the overall market? What should we expect as reasonable valuation for each of these catalysts? Anyone else looking forward to a partnership agreement soon? I do not want to be bought out. This company has been spending a lot of time and money preparing manufacturing facilities and I hope all this can be put to good use quickly.
GLTA HB
